Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
Anyone think we might get some news after the meeting on the 17th?
I am as worried about the placement of more shares as the next shareholder, and I was livid on Friday when the rns first came out. My main frustration is that the last placement was as I understood it, to get them through a few months cash burn prior to a deal. Bearing this in mind, val cannot negotiate a deal without the potential to raise funds to keep themselves going, or a pharma will just play hard ball until they have to sign the deal on the table. With the recent changes in language and commercial update I am willing to vote yes and hope for the deal to be signed on the back of this, and hope there is no further placing required. As hard as they make it, let's not forget the drugs we have are already proven to work, and on the back of recent news from FARN, IMM, N4P this value and fact should not be underestimated
I believe it's on the 1st, so on Friday. Fingers crossed we then get some clarity on what's happening one way or another!
I wouldn't hold your breath either apple, I'm 1 from 3 on email replies in the last year. They do come across is ignorant to our concerns, but I'll keep holding in the hope that the drugs are good enough to sell themselves!
https://esut18.uroweb.org/exponential-technological-development-poses-questions-future-surgeons/ Positive comments at the Urology conference about the adoption of AI in general
The interim results will be end of H1 I believe, but you're right on the full read out for the trial
Yeah agreed, looks good as an investment and should hopefully keep traders away!
Have you all read the presentation? No new info as the interim results have not been released, but looks good to bring in additional private investors. Can't imagine it'll make a big impact to sp initially though
I'm sure they just have GE as a distributor as well? A huge vote of confidence and then potential for sales, but still no sales yet. Unless I've missed something?
London in a Novotel
It's possible there's an rns that gives top line results, with more detail within a presentation so that's not an answer. Just wondered whether any indications had been made by the company
Is the presentation tomorrow definitely new results? I know the whole event is about gaining investment and deals from pharma but I thought it was possible this was more of a pitch. What you think?
Is it even possible for a main listing within the time-frames we've had here? Any feedback would be appreciated! Trying to be optimistic but like everyone else, the silence has always worried me. Good luck all!
Anyone had any recent contact with GW? Wondering if there's any indication this could be back in business next week?
An update on deals and figures would really get this going now. Fda approval and American sales will still be the big kick in June though imo. Exciting times
Looks to me like that 8.46 was probably a buy?
surely an update this week!